Last SFr.254.90 CHF
Change Today +0.70 / 0.28%
Volume 1.1M
ROG On Other Exchanges
Symbol
Exchange
OTC US
OTC US
OTC US
Xetra
SIX Swiss Ex
Xetra
SIX Swiss Ex
Mexico
Frankfurt
As of 11:43 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Osamu Nagayama

Chairman of The Board and Chief Executive Officer, Chugai Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 42 board members in 5 different organizations across 5 different industries.

See Board Relationships
66--

Background*

Mr. Osamu Nagayama served as the Chairman and Chief Executive Officer of Chugai Pharmaceutical Co. Ltd. since March 28, 2012. Mr. Nagayama served as President and Chief Operating Officer at Chugai Pharmaceutical Co. Ltd. until February 2012. He has been with Chugai Pharmaceutical Co. Ltd. since 1978. He served as a Director of Pharmaceutical Sales & Marketing Division and International Business Division of Chugai since 1983, Deputy General Manager of Pharmaceutical Research ...

Read Full Background

Corporate Headquarters*

Grenzacherstrasse 124
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

Chairman of The Board and Chief Executive Officer
2005-Present
Independent Director
2010-Present
Chairman of the Board and Member of Nominating Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.254.90 CHF +0.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.